Repurposing PPS
15 June, 2015Paradigm Biopharmaceuticals is raising funds to develop PPS (pentosan polysulphate sodium) as a superior treatment for BME (bone marrow oedema) and allergic rhinitis.
UniQuest and Janssen agreement focuses on immune system
15 June, 2015A new research and development deal is hoped will realise new treatments for ankylosing spondylitis psoriasis and inflammatory bowel disease.
Immune signals can predict cancer spread
15 June, 2015Australian researchers have discovered that the key to effective breast cancer treatment may lie in predicting the path the cancer plans to take.
IND reactivated for Prescient breast cancer drug
10 June, 2015The US FDA has reactivated the Investigational New Drug (IND) for the novel drug candidate PTX-100 (formerly known as GGTI-2418) in a phase Ib trial for the treatment of metastatic breast cancer.
How deadly ovarian cancer evades chemotherapy
03 June, 2015The largest complete DNA analysis of ovarian cancer in the world has revealed new insight into the genetic twists and turns a deadly form of the disease takes to outsmart chemotherapy. This groundbreaking work features contributions from several Australian facilities.
MRFF legislation introduced into parliament
27 May, 2015The federal government has introduced legislation to establish its much-anticipated Medical Research Future Fund (MRFF). Subject to the passage of the legislation, the fund will be established from 1 August 2015.
Telomere analysis centre to advance cancer research
25 May, 2015Westmead's Children's Medical Research Institute has become home to the Australian Cancer Research Foundation Telomere Analysis Centre (ATAC). The centre's opening coincides with recent CMRI research that illustrates why studying telomeres may lead to treatments for some of the most aggressive cancers.
Australian company licensed to export medicinal cannabis
21 May, 2015Australian company AusCann has been granted a landmark licence to grow and export medicinal cannabis from a secure Norfolk Island location, with the first plantings to commence in November this year.
Mapping insulin's path through the human body
21 May, 2015Researchers from the University of Sydney have published a diagram which charts, in unprecedented detail, the insulin/IGF1 signalling pathway (ISP) - a complex network of molecular interactions triggered by insulin which plays an essential role in long-term health, obesity and diseases such as diabetes.
Possible trigger for autoimmune disease discovered
15 May, 2015Scientists from the Garvan Institute of Medical Research claim to have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.
Funding announced for 19 NSW cancer projects
01 May, 2015Cancer Council NSW has announced almost $7 million in donations for 19 groundbreaking cancer research projects. The organisation received 143 applications for grants this year.
$1m program for early-career medical researchers
30 April, 2015A new $1 million program will give next-generation medical leaders a kick start by boosting their chances of receiving competitive grant funding.
Prescient appoints new CMO, presents preclinical data
29 April, 2015Prescient Therapeutics has announced the appointment of Dr Terrence Chew as its chief medical officer, as well as new data from a preclinical trial of its novel compound PTX-100 in multiple myeloma.
Minomic prostate cancer test more accurate than PSA
22 April, 2015A new trial has revealed that the prostate cancer blood test MiCheck, developed by Australian-owned biotech company Minomic International, is more than twice as accurate as existing prostate-specific antigen (PSA) screening technology.
Imugene candidate increases cancer-fighting antibodies
20 April, 2015Imugene has found that its lead candidate HER-Vaxx, an immunotherapy product for treatment of breast and gastric cancers, demonstrates a powerful increase in the production of cancer-fighting antibodies in preclinical animal model testing.
